| Literature DB >> 29398219 |
Alexandre F Carisey1, Emily M Mace2, Mezida B Saeed3, Daniel M Davis3, Jordan S Orange4.
Abstract
Natural killer (NK) cells are innate immune effectors that lyse virally infected and tumorigenic cells through the formation of an immunological synapse. Actin remodeling at the lytic immunological synapse is a critical requirement for multiple facets of cytotoxic function. Activating receptor and integrin signaling leads to the regulated turnover and remodeling of actin, which is required for adhesion, sustained receptor signaling, and ultimately exocytosis. NK cells undergo lytic granule exocytosis in hypodense regions of a pervasive actin network. Although these requirements have been well demonstrated, neither the dynamic regulation of synaptic actin nor its specific function, however, has been determined at a nanoscale level. Here, live-cell super-resolution microscopy demonstrates nanoscale filamentous actin dynamism in NK cell lytic granule secretion. Following cell spreading, the overall content of the branched actin network at an immune synapse is stable over time and contains branched actin fibers and discrete actin foci. Similar actin architecture is generated in cytolytic T cells, although the timescale differs from that of NK cells. Individual filament displacement leads to stochastic clearance formation and disappearance, which are independent of lytic granule positioning. Actin dynamism is dependent upon branched network formation mediated by Arp2/3 and contractility generated by myosin IIA. Importantly, the use of small-molecule inhibitors demonstrates that actin dynamism is ultimately needed for granule secretion. Thus, we describe a requirement for nanoscale actin fiber rearrangement in generating the complex actin architecture that enables lytic granule secretion. CrownEntities:
Keywords: actin cytoskeleton; cytotoxicity; degranulation; immune synapse; natural killer cell; super-resolution microscopy
Mesh:
Substances:
Year: 2018 PMID: 29398219 PMCID: PMC5835143 DOI: 10.1016/j.cub.2017.12.044
Source DB: PubMed Journal: Curr Biol ISSN: 0960-9822 Impact factor: 10.834
Figure 1Mature NK Cell Lytic Synapse Is Defined by a Pervasive F-Actin Network
(A) Representative frames from NK92.LifeAct-mEmerald stained with LysoTracker red and seeded on the indicated antibody-coated glass surface and imaged by live confocal microscopy. Scale bars, 5 μm.
(B and C) Spreading speed measured from initial cell contact (B) until the cell footprint reaches its plateau value reported (C). N = 37, 21, and 35 cells, respectively, per condition from 3, 4, and 4 independent experiments. The p value was calculated by one-way ANOVA Kruskal-Wallis test (Dunn’s) in (B) and ordinary one-way ANOVA with Tukey’s post hoc comparison in (C). n.s., not significant.
(D) Overlay of cell outlines throughout 30 min for each substrate condition (top row); the representative cells are from (A). Each outline was used to define a 2-μm-thick inner rim where the fluorescence intensity (F.I.) of the LifeAct-mEmerald probe was reported in the kymographs below. The small black arrowheads highlight the presence of the actin-rich lamellipodium. Scale bar, 10 μm.
(E) Z projection of a 3D volume from live confocal microscopy of HeLa target cells and NK92.LifeAct-mEmerald effectors (see Movie S1). The IS at the interface between target and effector cells is highlighted in yellow. Two representative ISs (red and green insets) are shown en face after a 90° rotation along the x axis (i.e., y axis projection). Representative image of 3 independent repeats. Scale bar, 10 μm.
(F) Single frames from live TIRF-SIM microscopy showing the continuous presence of actin fibers throughout the formation and maturation of the IS (from 2 to 5 min following initial contact with the glass). The color scheme of the images within the white square has been inverted, filtered and magnified below to allow the visualization of the dimmest structure while retaining the linearity of the fluorescence signal (see Movie S2). Representative images of 43 cells from 6 experiments are shown. Scale bar, 5 μm (top) and 1 μm (bottom).
(G) Frequency of NK92.LAMP1-pHluorin cells undergoing degranulation detected by TIRF microscopy at the times indicated. N = 60, 67, and 64 cells, respectively, per condition from 3 independent experiments.
Figure 2Granule-Permissive-Sized Clearances Persist following Degranulation and Are a Feature of NK and Cytotoxic T Cells
(A) Representative images of NK92 activated on anti-CD18- and anti-NKp30-coated glass for the times indicated, stained for F-actin, and imaged by time-gated STED microscopy. Scale bar, 5 μm.
(B) Quantification of the clearances/μm2 measured in activated NK92. Each data point represents one cell from N = 58, 59, 59, and 59 cells from 4 pooled independent repeats. The p value was calculated by ordinary one-way ANOVA with Tukey’s post hoc comparison.
(C) Quantification of mean hole area measured in fixed activated NK92 cells acquired by SIM at the indicated time points. N = 20 cells per condition; the experiment is representative of 3 independent repeats.
(D) Representative images of NK92.LifeAct-mTurquoise cells showing F-actin (gray), lytic granules (red), and CD107a (green). Scale bar, 5 μm. The kymograph (below) produced from the region highlighted by the red square shown for and showing F-actin (gray) and CD107a (green). Images are representative of 20 cells from 2 independent experiments.
(E) Primary human T cells were isolated from peripheral blood of healthy donors and activated on anti-CD3, anti-CD28, or anti-CD3/-CD28 for the times indicated prior to fixation and staining with phalloidin Alexa Fluor 488. Cells were imaged by time-gated STED microscopy. The regions inside the red boxes are magnified on the right of each panel. Scale bars, 5 μm and 1 μm (insets). Mean hole area was measured and is shown in the graph (right) of each condition. N = 10, 13, 24, 37, 41, 50, 49, 50, and 61 cells, respectively, pooled from 3 independent repeats. The p value was calculated by one-way ANOVA Kruskal-Wallis test (Dunn’s). Similar analysis was performed in primary T CD8+ and NK cells in Figure S2.
Figure 3Global Actin Stability at the Mature NK IS Is Coupled to Local F-Actin Dynamism
NK92.LifeAct-mEmerald cells were activated for 20 min prior to initiation of imaging by TIRF-SIM microscopy at 5-s intervals for 5 min. Scale bars, 5 μm. ps, post-spreading.
(A) Time-lapse series of a single cell representative of 43 cells from 6 independent experiments imaged showing stable actin level at the IS (see Figures S3A–S3D).
(B) Single frame of a time-lapse series of a representative cell (see Movie S5, left) with a transversal line indicating the axis used for the kymograph analysis in (C).
(C) Kymograph analysis of the LifeAct-mEmerald signal measured for 100 s (optical flow analysis; see Movie S3). The total signal is plotted on the top and the forward; backward and static components are below highlighting the stability of the edge regions of the mature NK IS (imaged 32 min post-spreading on the activating surface).
(D) Visualization of the nanoscopic dynamism within the cortical actin cytoskeleton in 4 regions indicated in their context in (B). The first row details the LifeAct-mEmerald signal over time. Below, the area of segmented clearances is color coded according to the color scale (right) and further analyzed below by indicating the clearances compatible with the extrusion of granules with size ranging from 200 to 800 nm (see Figure S3J and Movie S4). The last row visualizes the dynamism surrounding the sites of clearance formation as a result of filament rearrangement using optical flow mapping.
(E and F) Plot (E) and count (F) of the area of the clearances above 0.5 μm2 over the time course of the super-resolved time lapse (see Movie S5). Clearances continuously appear and disappear on a short timescale within the cortical actin mesh at the mature IS of NK cells.
Figure 4Foci Are Present at Sites of Local Actin Rearrangement
(A and B) Representative NK92.LifeAct-mEmerald cell activated (A) (inverted color from Figure 3B) for 20 min on anti-CD18 and anti-NKp30 prior to imaging by TIRF-SIM including F-actin foci that undergo dynamic behaviors highlighted by the orange arrowheads in the time series in (B) (see Movie S6). Colored tracks indicate their displacement over 95 s. Scale bars, 5 μm (A) and 1 μm (B).
(C) Quantification of the lifetime of the actin foci. Data are pooled from 20 cell averages at 42 s ± 43.3 s. Additionally, a small proportion (3.06%) of all actin foci measured have a turnover longer than the acquisition of the time lapse (>3 min).
(D) Quantification of the number of F-actin-rich foci in NK92 cells activated for 10 min prior to administration of 50 μM CK666 for an additional 20 min. Images were acquired by time-gated STED microscopy, and the number of F-actin foci present at the synapse were measured using image segmentation. N = 10 and 13 cells, respectively, from 1 experiment representative of 4 experiments. The p value was calculated by Mann-Whitney unpaired two-tailed test.
(E) Representative live-cell imaging experiment using TIRF-SIM where NK92.LifeAct-mEmerald cells have been plated on an antibody-coated surface and imaged through the treatment and washout of 50 μM CK666. The actin foci are sensitive to inhibition of CK666 but recover shortly after washout of the compound (see Movie S7). The cell is representative of 12 cells from 4 independent repeats. Scale bar, 5 μm.
Figure 5Maintenance and Dynamism of Actin Clearances at the Lytic Synapse Allow Degranulation
(A) F-actin (gray) and perforin (red) staining acquired by STED microscopy of NK92 cells activated on anti-CD18- and anti-NKp30-coated glass for 20 min prior to addition of 50 μM CK666 or DMSO for 10 min. Shown is one representative cell from each condition of greater than 100 cells per condition from 4 independent experiments. Scale bar, 2 μm.
(B) Frequency of granule-permissive clearances was calculated from cells acquired as in (A). N = 41 per condition from 2 experiments pooled representative of 4 experiments performed. The p value was calculated by unpaired t test with Welch’s correction two-tailed test; outliers were removed by robust regression and outlier removal (ROUT) (1%).
(C) Co-localization between perforin and phalloidin at the site of each granule for cells acquired as in (A). Each data point represents a single granule. N = 50 per condition from 2 pooled independent experiments representative of 4 repeats. The p value was calculated by Mann-Whitney unpaired two-tailed test; outliers were removed by ROUT (1%).
(D) Live-cell time lapses of NK92 cells expressing mApple-LAMP1-pHluorin were acquired by TIRF following 20 min of activation and 10 min of treatment. Degranulations were measured as explained in STAR Methods (Figure S5). The number of events of degranulation observed per min is reported with one cell for each data point. N = 41, 28, 31, and 15 cells, respectively, pooled from 3 independent repeats. The p value was calculated by one-way ANOVA Kruskal-Wallis test (Dunn’s); outliers were removed by ROUT (1%).
(E) NK92.LifeAct-mTurquoise cells activated as above and image series captured by live-cell STED following 10 min of CK666 treatment. Representative images from 24 cells from 4 experiments are shown. Scale bar, 2 μm.
(F) Kymograph analysis using a line profile of the regions indicated in (E). Scale bar, 0.5 μm.
(G) NK92 cells treated with blebbistatin, stained for F-actin, and imaged by fixed-cell STED microscopy. Scale bar, 2 μm.
(H) Cells were quantified for the presence of granule-permissive-sized clearances. N = 41 and 38 cells, respectively, from 2 pooled independent experiments representative of 4 repeats (see Figure S4B). Each data point represents a single cell. The p value was calculated by Mann-Whitney unpaired two-tailed test; outliers were removed by ROUT (1%).
(I) Cells treated with blebbistatin and imaged by live-cell TIRF microscopy were enumerated for the number of granules in the TIRF field as detected by LysoTracker staining. N = 48 and 39 cells, respectively, from 2 pooled independent experiments representative of 4 repeats. The p value was calculated by Mann-Whitney unpaired two-tailed test; outliers were removed by ROUT (1%). PM, plasma membrane.
Figure 6Actin Filament and Lytic Granule Movement Occur Independently
NK92.LifeAct-mTurquoise cells were labeled with LysoTracker red prior to activation on anti-CD18- and anti-NKp30-coated glass for 20 min and then imaging of single cells at 10-s intervals by STED microscopy.
(A) Representative cells highlighting a 3 × 3 μm region of interest that includes the capture of a granule appearance (top) or disappearance (bottom) during the time of imaging. Scale bar, 1 μm.
(B) Kymograph analysis using a line profile of the regions indicated in (A) (x axis) measured over time (y axis). Three situations are illustrated: granule appearance in an existing clearance (top), stationary granule over dynamic actin filaments (middle), and granule disappearance through a closing clearance (bottom). Scale bars, 0.75 μm.
(C) Line profile analysis of granule appearance shown by the vertical dashed line shown in (B). The mean of 6 granules is shown normalized to their arrival in the imaging field of view (one example of a granule intensity profile is in red). Individual line profiles of F-actin over the granule are shown in green. MFI, mean fluorescence intensity.
(D) Individual line profile (dashed vertical line) across the kymograph of the disappearing granule shown in (B). Data are representative of 24 cells from 3 independent experiments.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| CD8-Bv785 (staining concentration 6 μg/mL) | Biolegend | Cat#301045; Clone RPTA-T8; Lots B187390, B221662 |
| CD45RA-Bv421 (staining concentration 6 μg/mL) | Biolegend | Cat#304129; Clone HT100; Lot B204474 |
| CD45RO-PE (staining concentration 5 μg/mL) | Biolegend | Cat#304205; Clone UCHL1; Lot B183218 |
| CD107a-AF647 (staining concentration 1.25 μg/mL) | Biolegend | Cat#328612; Clone H4A3; Lot E11642-1632 |
| Perforin-AF488 (staining concentration 20 μg/mL) | Biolegend | Cat#308108; Clone dG9; Lot B198112 |
| CD3 (LEAF) (concentration 5 μg/mL) | Biolegend | Cat#317315; Clone OKT3; Lot B211929 |
| CD28 (concentration 5 μg/mL) | Biolegend | Cat#302914; Clone CD28.2; Lot B219506 |
| CD18 (concentration 5 μg/mL) | Hybridoma | Clone TS1/18; Single batch |
| CD18 (concentration 5 μg/mL) | Hybridoma | Clone IB4; Single batch |
| NKp30 (LEAF, CD337) (concentration 5 μg/mL) | Biolegend | Cat#325204; Clone P30-15; Lot B224416 |
| NKp30 (CD337) (staining concentration 5 μg/mL) | R&D Systems Europe | Cat#MAB18491; Clone 210847; Lot JRK0216081 |
| rh ICAM-1 (concentration 5 μg/mL) | R&D Systems | Cat#ADP4-200; Lot WV1915121 |
| Phalloidin AF488 (staining concentration 3U/mL) | Thermo Fisher | Cat#A12379; Lot 1816955 |
| Phalloidin AF532 (staining concentration 3U/mL) | Thermo Fisher | Cat#A22282; Lot 1417648 |
| LysoTracker Red DND-99 (staining concentration 1/1000) | Thermo Fisher | Cat#L7528; Lot 983858 |
| Cell Proliferation Dye eFluor 670 (staining concentration 1/1000) | eBioscience | Cat#65-0840-85; Lot 4297564 |
| SYTOX Orange Nucleic Acid Stain (staining concentration 0.2 μM) | Thermo Fisher | Cat# S11368; Lot 1488607 |
| DMSO, Anhydrous (dilution 1/500, 1/1000) | Thermo Fisher | Cat#D12345 |
| Blebbistatin (concentration 40 μM) | Sigma Aldrich | Cat#B0560-1MG; Lot SLBM5499V |
| CK666 (concentration 50 μM) | Calbiochem | Cat#182515-25MG; Lot 264765 |
| Jasplakinolide (concentration 1 μM) | ChemCruz | Cat#sc-202191A; Lot A0417 |
| SMIFH2 (concentration 50 μM) | Sigma Aldrich | Cat#S4826-5MG; Lot 075M4601V |
| Human CD8+ T cell enrichment kit | Stemcell | Cat#15063; Lot 16F72180 |
| T Cell Expansion Kit, human | Miltenyi Biotec | Cat#130-091-441; Lot 5150227115 |
| NK Cell Isolation Kit, human | Miltenyi Biotec | Cat#130-092-657; Lot 5170608527 |
| LookOut mycoplasma PCR detection kit | Sigma Aldrich | Cat#MP0035-1KT |
| Amaxa Kit R | Lonza | Cat#VCA-1001 |
| NK92 | ATCC | Cat#CRL-2407 |
| Human: healthy donor | Sample size is indicated in the legend of each relevant figure. | All samples were acquired with approval from the Institutional Review Boards of Texas Children’s Hospital and University of Manchester under the guidelines of the Declaration of Helsinki. |
| LAMP1-pHluorin plasmid | [ | N/A |
| mApple-LAMP1-pHluorin-N-8 plasmid | Davidson Collection (unpublished) | AddGene Plasmid #54918 |
| LifeAct plasmid | Dr Janis Burkhardt (University of Pennsylvania) | N/A |
| LeGO-E Emerald-GFP plasmid | Dr. Boris Fehse | AddGene Plasmid #27359 |
| mTurquoise plasmid | Dr. Theodorus Gadella (University of Amsterdam) | N/A |
| Imaris (v8.4.1 and v9.0.2) | Bitplane | |
| MATLAB (v2016b and v2017b) | The MathWorks | |
| Huygens (v16.10) | Scientific Volume Imaging | |
| Volocity (v6.3) | Perkin Elmer | |
| Fiji v1.51n | [ | |
| NanoJ toolbox for ImageJ | [ | |
| QuimP toolbox for ImageJ v17.04.04 | [ | |
| KymographClear Macro toolset for ImageJ | [ | |
| LookUp Tables | Dr David J Williamson (King’s College, London) | |
| Actin Mesh Analyzer | [ | |
| GraphPad Prism 7.03 | GraphPad Software | |
| DSS Research online tool (statistical power calculation) | DSS Research | |
| Illustrator CC 22.0.1 (64-bit) | Adobe Systems Incorporated | |
| Figure | Method | Frame rate | Duration | Pixel size (final image) | Average FWHM measured using a thin fibrillar structure |
|---|---|---|---|---|---|
| Confocal | Every 15 s | 30 min | 89 nm | - | |
| Confocal | Every 51-80 s | 60 min | 113 nm | - | |
| Confocal | Every 15 s | 30 min | 89 nm | - | |
| Confocal | Every 89 s | 90 min | 180 nm xy, 800 nm z | - | |
| TIRF-SIM | Every 10 s | 10 min | 40 nm | 130 nm | |
| TIRF | 1 frame | - | 65 nm | 250 nm | |
| STED | Fixed | - | 40 nm | 120 nm | |
| STED | Fixed | - | 40 nm | 120 nm | |
| SIM | Fixed | - | 40 nm | 130 nm | |
| STED | Every 10 s | 3 min | 30 nm | 150 nm | |
| STED | Fixed | - | 30 nm | 120 nm | |
| TIRF-SIM | Every 5 s | 5 min | 40 nm | 130 nm | |
| TIRF-SIM | Every 5 s | 5 min | 40 nm | 130 nm | |
| STED | Fixed | - | 30 nm | 120 nm | |
| TIRF-SIM | Every 5 s | Discontinuous (drug treatment, washout) | 40 nm | 130 nm | |
| STED | Fixed | - | 30 nm | 150 nm | |
| TIRF | Every 1 s | 5 min | 65 nm | 250 nm | |
| STED | Every 10 s | 3 min | 50 nm | 180 nm | |
| STED | Fixed | - | 30 nm | 150 nm | |
| STED | Every 10 s | 3 min | 30 nm | 150 nm | |
| Confocal | Every 51-80 s | 60 min | 113 nm | - | |
| Confocal | Every 2min | 60 min | 113 nm | - | |
| 3D-SIM | Fixed | - | 40 nm xy, 125 nm z | 130 nm xy, 300 nm z | |
| 3D-STED | Fixed | - | 30 nm xy, 100 nm z | 120 nm xy, 250 nm z | |
| STED | Fixed | - | 30 nm | 120 nm | |
| TIRF-SIM | Every 3 s | 1 min | 40 nm | - | |
| STED | Every 10 s | 2 min | 50 nm | - | |
| TIRF-SIM | Every 5 s | 5 min | 40 nm | 130 nm | |
| STED | Every 10 s | 2 min | 50 nm | 180 nm | |
| STED | Every 10 s | 2 min | 50 nm | 180 nm | |
| STED | Every 1 s | 15 s | 50 nm | 180 nm | |
| STED | Every 10 s | 1 min 50 s | 50 nm | 180 nm | |
| TIRF-SIM | Every 5 s | 5 min | 40 nm | 130 nm | |
| TIRF-SIM | Every 5 s | 5 min | 40 nm | 130 nm | |
| Confocal | 1 frame | - | 568 nm | - | |
| TIRF-SIM | Every 5 s | Discontinuous for drug treatment and washout | 40 nm | 130 nm | |
| Confocal | Every 1 min | Discontinuous for drug treatment and washout | 101 nm | 230 nm | |
| TIRF | Every 1 s | 5 min | 65 nm | 250 nm |
| Figure | Sample size and repeat | Statistical test | Outlier removal |
|---|---|---|---|
| Representative images from 3 independent repeats with 10 cells each time. | N/A | N/A | |
| N = 37, 21 and 35 cells respectively per condition from 3, 4 and 4 independent experiments respectively | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| N = 37, 21 and 35 cells respectively per condition from 3, 4 and 4 independent experiments respectively | Ordinary one-way ANOVA with Tukey’s post hoc comparison | No | |
| Representative cells from | N/A | N/A | |
| Representative images selected from 3 independent repeats | N/A | N/A | |
| Representative images selected from 43 cells from 6 experiments | N/A | N/A | |
| N = 60, 67, 64 respectively from 3 independent experiments | N/A | N/A | |
| Representative images selected from more than 65 cells per condition pooled from 5 independent repeats | N/A | N/A | |
| N = 58, 59, 59 and 59 cells respectively per condition pooled from 4 independent repeats | Ordinary one-way ANOVA with Tukey’s post hoc comparison | No | |
| N = 20 cells per condition from 1 experiment representative of 3 independent repeats | One-way ANOVA Kruskal-Wallis test (Dunn’s) | ROUT 1% | |
| Representative images selected from 20 cells from 2 independent repeats | N/A | N/A | |
| N = 10, 13, 24, 37, 41, 50, 49, 50 and 61 cells respectively pooled from 3 independent repeats | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| Representative images selected from 43 cells from 6 independent repeats | N/A | N/A | |
| Representative images selected from 43 cells from 6 independent repeats | N/A | N/A | |
| Quantification from dataset presented in | N/A | N/A | |
| Representative images selected from 43 cells from 6 independent repeats | N/A | N/A | |
| Quantification from dataset presented in | N/A | N/A | |
| Quantification from dataset presented in | N/A | N/A | |
| Representative images selected from 43 cells from 6 independent repeats | N/A | N/A | |
| Details from dataset presented in | N/A | N/A | |
| N = 20 cells from 4 independent repeats | N/A | No | |
| N = 10 and 13 cells respectively from 1 experiment representative of 4 independent repeats | Mann-Whitney, two-tailed test | No | |
| Representative images selected from 12 cells from 4 independent repeats | N/A | N/A | |
| Representative images selected from more than 100 cells imaged from 4 independent repeats | N/A | N/A | |
| N = 41 per condition from 2 pooled independent experiments representative of 4 independent repeats | Unpaired t-test with Welch’s correction, two-tailed | ROUT 1% | |
| N = 50 per condition from 2 pooled independent experiments representative of 4 independent repeats | Unpaired Mann-Whitney, two-tailed test | ROUT 1% | |
| N = 41, 28, 31 and 15 cells respectively per condition pooled from 3 independent repeats | One-way ANOVA Kruskal-Wallis test (Dunn’s) | ROUT 1% | |
| Representative images selected from 24 cells from 4 experiments | N/A | N/A | |
| Representative images selected from 24 cells from 4 experiments | N/A | N/A | |
| Representative images selected from 41 and 38 cells respectively from 4 experiments | N/A | N/A | |
| N = 41 and 38 cells respectively from two pooled independent experiments representative of 4 repeats | Unpaired Mann-Whitney, two-tailed test | ROUT 1% | |
| N = 48 and 39 cells respectively from two pooled independent experiments representative of 4 repeats | Unpaired Mann-Whitney, two-tailed test | ROUT 1% | |
| Data representative of 24 cells from 3 independent experiments. | N/A | N/A | |
| Data representative of 24 cells from 3 independent experiments. | N/A | N/A | |
| Data representative of 24 cells from 3 independent experiments (MFI of actin at the location of 6 granules normalized to their arrival, 1 example of granule in red) | N/A | N/A | |
| Data representative of 24 cells from 3 independent experiments (MFI of actin at the location of 1 granule normalized to their arrival, 1 example of granule in red) | N/A | N/A | |
| N = 37, 21 and 35 cells respectively per condition from 3, 4 and 4 independent experiments respectively | N/A | N/A | |
| Representative images selected from 7 independent repeats | N/A | N/A | |
| Representative image selected from 1 repeat from 2C | N/A | N/A | |
| Representative image selected from 1 repeat from 2A | N/A | N/A | |
| Representative images selected from 17 cells | N/A | N/A | |
| N = 11 cells pooled from 2 independent repeats | N/A | N/A | |
| N = 11 cells pooled from 2 independent repeats | N/A | N/A | |
| Representative images selected from S2EF | N/A | N/A | |
| N = 10 cells per condition per donor for 4 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| N = 10 cells per condition per donor for 4 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| Representative images selected from S2HI | N/A | N/A | |
| N = 10 cells per condition per donor for 4 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| N = 10 cells per condition per donor for 4 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| Representative images selected from S2KL | N/A | N/A | |
| N = 10 cells per condition per donor for 3 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| N = 10 cells per condition per donor for 3 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| Representative images selected from S2NO | N/A | N/A | |
| N = 10 cells per condition per donor for 4 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| N = 10 cells per condition per donor for 4 donors, each donor colored individually | One-way ANOVA Kruskal-Wallis test (Dunn’s) | No | |
| N = 33 cells pooled from 6 independent repeats | N/A | N/A | |
| N = 33 cells pooled from 6 independent repeats | N/A | N/A | |
| N = 6 cells from 1 experiment representative of 3 independent repeats | N/A | N/A | |
| N = 7 cells from 1 experiment representative of 3 independent repeats | Unpaired Mann-Whitney, two-tailed test | No | |
| Representative images selected from 43 cells from 6 independent repeats | N/A | N/A | |
| Representative images selected from 25 cells from 3 independent experiments | N/A | N/A | |
| N = 5 cells from 1 experiment representative of 3 independent repeats | N/A | N/A | |
| N = 6 cells from 1 experiment representative of 3 independent repeats | N/A | N/A | |
| N = 10 cells from 1 experiment representative of 3 independent repeats | Unpaired Mann-Whitney, two-tailed test | No | |
| Representative images selected from 43 cells from 6 independent repeats | N/A | N/A | |
| Representative images selected from 28 cells from 3 experiments | N/A | N/A | |
| N = 3846, 3451, 2358, 3829, 5124, 2476 and 4125 cells respectively from a representative experiment of 2 repeats. | N/A | N/A | |
| Representative images selected from 12 cells from 4 independent repeats | N/A | N/A | |
| N = 10 cells from a representative experiment out of 6 independent repeats (error bars represent 95% CI). | N/A | N/A | |
| N = 10 cells from a representative experiment out of 6 independent repeats (error bars represent 95% CI). | N/A | N/A | |
| N = 10 cells from a representative experiment out of 6 independent repeats (error bars represent 95% CI). | N/A | N/A | |
| N/A | N/A | N/A | |
| N = 6 representative traces from 11 cells from dataset used in | N/A | N/A | |
| Representative images selected from 11 cells from dataset used in | N/A | N/A | |
| N = 11 and 15 cells respectively from 1 experiment representative of 3 independent repeats | Unpaired t-test with Welch’s correction, two-tailed | No | |
| N = 11 and 15 cells respectively from 1 experiment representative of 3 independent repeats | Unpaired t-test with Welch’s correction, two-tailed | No | |
| N = 11 and 15 cells respectively from 1 experiment representative of 3 independent repeats | N/A | No | |
| N = 11 and 15 cells respectively from 1 experiment representative of 3 independent repeats | N/A | No | |
| N = 11 and 15 cells respectively from 1 experiment representative of 3 independent repeats | N/A | No | |
| N = 11 and 15 cells respectively from 1 experiment representative of 3 independent repeats | N/A | No |